Covid-19 Information

Latest News

AZ vaccine Important Info

While the detailed case review is ongoing, it is important to ensure all health professionals are alert to relevant symptoms which require further clinical review.... read more

COVID-19 Vaccine Use in UAE

Ministry of Health and Prevention (MOHAP) has announced that the UAE has authorized the emergency use of the Covid-19 vaccine; making it available to first line defence workers, protecting them from any danger that they may be exposed to due to the nature of their work

Vaccination trials

Many countries and companies are  conducting vaccination trials 

1. Moderna
2. Biontech
3. Aztrazaneca
4. Russian Adenovirus vaccine Sputnik V

For latest info on COVID-19 vaccine trials, visit:

https://www.nih.gov/news-events/news-releases/promising-interim-results-clinical-trial-nih-moderna-covid-19-vaccine

https://www.mohap.gov.ae/en/MediaCenter/News/Pages/2612.aspx

Approved Medical Treatment for COVID-19

On Nov. 23, the FDA approved an abbreviated new drug application for dexmedetomidine hydrochloride in 0.9% sodium chloride injection, indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive-care setting and sedation of non-intubated patients prior to and/or during surgical and other procedures. The most common side effects of dexmedetomidine hydrochloride injection are hypotension (low blood pressure), bradycardia (slow heart rate), and dry mouth. This drug is listed in the FDA Drug Shortage Database.

Antiviral drug Veklury (Remesdivir) was approved by FDA for the COVID-19 treatment or use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval.  https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19